[1]
“Evaluation of cardiovascular disease and fatty liver disease in type 2 diabetes subjects on ultrasonography”, Int. Res. J. Pharm., vol. 15, no. 6, pp. 17–21, Nov. 2024, Accessed: Jun. 01, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/88